TokenPost·
Biohaven Shares Rise About 25% After FDA Accepts Resubmission
25%
share price gain
The agency set a first-quarter 2027 user-fee goal date and plans to convene an advisory committee, with no meeting date announced.
More news
- TokenPostUniversal High Income Leads Crypto Searches After 45.11% Daily Gain
- TokenPostPerceptron Plans Walrus Storage Shift for 800,000-Plus AI Network
- TokenPostBitfinex XRP Long Positions Reach 5.07 Million XRP on Oct. 20
- TokenPostJapan Adds Shiba Inu to Green List Alongside Bitcoin and Ether
- TokenPostAttackers Used AI Agents in Crypto Scams and Health Care Intrusions
- TokenPostUniswap Labs Launches v4 Aggregator Hooks on Three Networks